Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Endocrinology

Treatment Options: Protecting Your Nerves and Managing Pain

At a Glance

Treatment for diabetic neuropathy combines blood sugar, blood pressure, cholesterol, weight, activity, and smoking management with medicines or topical therapies to reduce pain. Doctors usually start low and increase slowly because side effects and other health conditions affect the safest choice.

Managing diabetic neuropathy is a two-part process. The first goal is to protect your nerves from further injury by managing your overall health. The second goal is to treat the “volume” of the pain to help you sleep, move, and live more comfortably.

It is important to have realistic expectations: medications for nerve pain rarely eliminate it entirely. Instead, doctors aim for a meaningful reduction—typically a 30% to 50% improvement in pain and a significant boost in your quality of life [1][2].

Slowing Progression: The Metabolic Shield

To protect your nerves, your care team focuses on “multifactorial” management. This means looking at more than just your blood sugar.

  • Blood Sugar (Glycemic Control): Keeping your blood sugar in your individualized target range is the most effective way to slow nerve damage. This effect is strongest in Type 1 Diabetes, where intensive control can significantly reduce the risk of developing neuropathy [3][4]. Do not aggressively lower glucose on your own; a very rapid drop can rarely cause treatment-induced painful neuropathy.
  • Type 2 Considerations: In Type 2 Diabetes, glucose control is important, but often not enough to stop neuropathy [5]. For these patients, managing other “cardiometabolic” risks is essential [6].
  • The Big Picture: Managing your blood pressure, cholesterol (lipids), and weight, while staying active and not smoking, all work together to create a healthier environment for your nerves [6][7].

First-Line Medications for Pain

When nerve pain interferes with your daily life, your doctor may recommend one of several first-line medications. There is no “best” drug; the choice depends on your other health conditions and how your body reacts to side effects [8][9]. Do not start, stop, or combine these drugs without your prescriber, as sudden stopping can cause withdrawal. Note: Opioids (narcotics) are generally not first-line due to addiction and other harms.

Medication Class Common Examples How it Works Potential Side Effects & Safety
SNRIs Duloxetine (Cymbalta), Venlafaxine Increases chemical messengers in the brain that help “mute” pain signals [10]. Nausea, sleepiness, dizziness, dry mouth. Watch for blood pressure changes and withdrawal symptoms if stopped abruptly [11].
Gabapentinoids Pregabalin (Lyrica), Gabapentin (Neurontin) Calms overactive nerves by modulating calcium channels [9]. Dizziness, sleepiness, swelling in the legs (edema). Requires kidney dose adjustments. Severe breathing risk if combined with opioids or alcohol [12].
Tricyclic Antidepressants Amitriptyline, Nortriptyline An older class of meds often used at low doses to help with pain and sleep [8]. Dry mouth, constipation, dizziness when standing. Risky for those with heart rhythm problems or glaucoma [13].

Understanding the “Numbers”

Medical studies use a “Number Needed to Treat” (NNT) to show how effective a drug is compared to placebo. For example, an NNT of 7 means that for every 7 people who take the drug during a study, one additional person will achieve at least 50% pain relief compared to those who took the placebo [1]. Because class-wide figures vary, it is important to focus on finding the right treatment for your individual response.

Topical and Alternative Options

If you cannot tolerate oral medications or if your pain is focused in a very small area, topical treatments (creams or patches) may be an option.

  • Capsaicin 8% Patch: This high-strength patch uses the “heat” from chili peppers to desensitize pain receptors. It is applied by trained clinical staff to intact skin, and can cause temporary burning and blood pressure changes [14][15].
  • Lidocaine 5% Plaster/Patch: This numbs the surface of the skin. It is generally well-tolerated and has a low risk of interacting with other drugs, but should never be applied to open or damaged skin [16][17].
  • Non-Drug Therapies: Techniques like Cognitive Behavioral Therapy (CBT) or mindfulness can help you manage the emotional burden of chronic pain. Physical therapies like TENS (Transcutaneous Electrical Nerve Stimulation) may also provide relief for some people, though evidence varies [18][19].

Why the “Slow” Approach?

Your doctor will likely “start low and go slow” [20]. This means starting with a small dose and gradually increasing it over several weeks. This gives your brain and body time to adjust, which reduces the chance of side effects and helps you find the lowest effective dose for your unique situation [9][21]. If one drug doesn’t work or causes too many side effects, your doctor may switch you to another class or, in some cases, combine two different types of medication [13][18].

Common questions in this guide

What is the goal of treatment for diabetic neuropathy pain?
Treatment has two goals: slow further nerve damage by managing blood sugar and other health risks, and reduce pain enough to improve sleep, movement, and quality of life. Medicines often reduce pain rather than remove it completely, so a meaningful improvement may be around 30% to 50%.
Which medicines are commonly used first for diabetic nerve pain?
Common first choices include duloxetine or venlafaxine, pregabalin or gabapentin, and low-dose medicines such as amitriptyline or nortriptyline. The safest option depends on your other health conditions, kidney function, other medicines, and possible side effects.
How does kidney function affect diabetic neuropathy treatment?
Kidney function is especially important when using pregabalin or gabapentin because their doses may need adjustment. Tell your prescriber about kidney problems and all medicines you take so the treatment can be selected and monitored safely.
Why does my doctor start diabetic neuropathy medicine at a low dose?
Starting with a low dose and increasing it gradually gives your body time to adjust. This approach can reduce side effects and help your clinician find the lowest dose that provides useful pain relief.
Can patches or creams help diabetic nerve pain?
Topical capsaicin 8% or lidocaine 5% may help when pain is limited to a small area or oral medicines are difficult to tolerate. Capsaicin is applied by trained clinical staff, and lidocaine should not be placed on open or damaged skin.
What happens if the first diabetic neuropathy medicine does not help enough?
Your clinician may adjust the dose, switch to another medicine class, or sometimes combine two treatments. Non-drug options such as cognitive behavioral therapy, mindfulness, or physical therapy may also support pain management.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my latest labs, are my blood pressure and cholesterol levels in a good range to help protect my nerves?
  2. 2.Which medication should we start with, and what are the most common side effects I should watch for?
  3. 3.Since I also have [other condition, e.g., kidney issues or high blood pressure], how does that change which medication is safest for me?
  4. 4.What is our 'target dose' for this medication, and how slowly will we increase it to help my body adjust?
  5. 5.If this first medication doesn't give me at least 30-50% pain relief, what is our next step for pain management or physical therapy?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.

    Finnerup NB, Attal N, Haroutounian S, et al.

    The Lancet. Neurology 2015; (14(2)):162-73.

    PMID: 25575710
  2. 2

    Painful Diabetic Peripheral Neuropathy: Practical Guidance and Challenges for Clinical Management.

    Preston FG, Riley DR, Azmi S, Alam U

    Diabetes, metabolic syndrome and obesity : targets and therapy 2023; (16()):1595-1612 doi:10.2147/DMSO.S370050.

    PMID: 37288250
  3. 3

    Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.

    Braffett BH, Gubitosi-Klug RA, Albers JW, et al.

    Diabetes 2020; (69(5)):1000-1010 doi:10.2337/db19-1046.

    PMID: 32051148
  4. 4

    Prevention of Peripheral Distal Polyneuropathy in Patients with Diabetes: A Systematic Review.

    Carvajal-Moreno L, Coheña-Jiménez M, García-Ventura I, et al.

    Journal of clinical medicine 2022; (11(6)) doi:10.3390/jcm11061723.

    PMID: 35330052
  5. 5

    Diabetic neuropathy.

    Feldman EL, Callaghan BC, Pop-Busui R, et al.

    Nature reviews. Disease primers 2019; (5(1)):41 doi:10.1038/s41572-019-0092-1.

    PMID: 31197153
  6. 6

    Management of diabetic neuropathy.

    Cernea S, Raz I

    Metabolism: clinical and experimental 2021; (123()):154867 doi:10.1016/j.metabol.2021.154867.

    PMID: 34411554
  7. 7

    Development and validation of a risk prediction model for early diabetic peripheral neuropathy based on a systematic review and meta-analysis.

    Liu X, Chen D, Fu H, et al.

    Frontiers in public health 2023; (11()):1128069 doi:10.3389/fpubh.2023.1128069.

    PMID: 36908480
  8. 8

    Conventional management and current guidelines for painful diabetic neuropathy.

    Tesfaye S, Kempler P

    Diabetes research and clinical practice 2023; (206 Suppl 1()):110765 doi:10.1016/j.diabres.2023.110765.

    PMID: 38245323
  9. 9

    Diabetes: how to manage diabetic peripheral neuropathy.

    Gandhi M, Fargo E, Prasad-Reddy L, et al.

    Drugs in context 2022; (11()) doi:10.7573/dic.2021-10-2.

    PMID: 35775075
  10. 10

    Treating Painful Diabetic Peripheral Neuropathy: An Update.

    Snyder MJ, Gibbs LM, Lindsay TJ

    American family physician 2016; (94(3)):227-34.

    PMID: 27479625
  11. 11

    Efficacy and safety of duloxetine in painful diabetic peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials.

    Wu CS, Huang YJ, Ko YC, Lee CH

    Systematic reviews 2023; (12(1)):53 doi:10.1186/s13643-023-02185-6.

    PMID: 36945033
  12. 12

    The efficacy of pregabalin in patients with moderate and severe pain due to diabetic peripheral neuropathy.

    Parsons B, Li C

    Current medical research and opinion 2016; (32(5)):929-37 doi:10.1185/03007995.2016.1151776.

    PMID: 26854578
  13. 13

    Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.

    Tesfaye S, Sloan G, Petrie J, et al.

    Lancet (London, England) 2022; (400(10353)):680-690 doi:10.1016/S0140-6736(22)01472-6.

    PMID: 36007534
  14. 14

    Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.

    Simpson DM, Robinson-Papp J, Van J, et al.

    The journal of pain 2017; (18(1)):42-53 doi:10.1016/j.jpain.2016.09.008.

    PMID: 27746370
  15. 15

    Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.

    Vinik AI, Perrot S, Vinik EJ, et al.

    BMC neurology 2016; (16(1)):251 doi:10.1186/s12883-016-0752-7.

    PMID: 27919222
  16. 16

    Topical analgesics for neuropathic pain: an evidence-informed guide for the practicing clinician.

    Lawson E, Singla P, Adler J, et al.

    Pain medicine (Malden, Mass.) 2026; (27(3)):279-316 doi:10.1093/pm/pnaf130.

    PMID: 41017645
  17. 17

    The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence.

    de León-Casasola OA, Mayoral V

    Journal of pain research 2016; (9()):67-79 doi:10.2147/JPR.S99231.

    PMID: 26929664
  18. 18

    Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations.

    Moisset X, Bouhassira D, Avez Couturier J, et al.

    Revue neurologique 2020; (176(5)):325-352 doi:10.1016/j.neurol.2020.01.361.

    PMID: 32276788
  19. 19

    Evidence-Based Treatment of Painful Diabetic Neuropathy: a Systematic Review.

    D'Souza RS, Barman R, Joseph A, Abd-Elsayed A

    Current pain and headache reports 2022; (26(8)):583-594 doi:10.1007/s11916-022-01061-7.

    PMID: 35716275
  20. 20

    Treatment of diabetic peripheral neuropathy: a review.

    Khdour MR

    The Journal of pharmacy and pharmacology 2020; (72(7)):863-872 doi:10.1111/jphp.13241.

    PMID: 32067247
  21. 21

    Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.

    Tesfaye S, Sloan G, Petrie J, et al.

    Health technology assessment (Winchester, England) 2022; (26(39)):1-100 doi:10.3310/RXUO6757.

    PMID: 36259684

This page is for informational purposes only and does not constitute medical advice. Your clinician should choose and adjust diabetic neuropathy treatments based on your health conditions, kidney function, and medicines.

Get notified when new evidence is published on diabetic neuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.